# Wentao Innovative Drug Research (Beijing) Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/wentao-innovative-drug-research-beijing-co

- Industry: Biotechnology
- Headquarters: Beijing, China
- Total disclosed funding: $1.5M
- Latest round: Series A (Jul 28, 2022)
- Investors on record: 1

## About

Based in Beijing, China, and founded in 2016, Wentao Innovative Drug Research (Beijing) Co., Ltd is a pharmaceutical company engaged in R & D and production of new drugs. The company has a new drug research and development center, drug production base, API production base, and drug sales agent cooperation.

The company can realize dosage form improvement for children's drugs, geriatric drugs,  and chronic disease drugs, and fixed-point release of compound formulations through microsphere technology. The company has several new drugs under clinical BE validation. It can achieve a production capacity of more than 200,000 preparations per day.

## Funding rounds

- Series A, Jul 28, 2022, $1.5M — Heda Capital

## Investors

- Heda Capital (https://capitalatlas.ai/funds/heda-capital) — Series A